PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
Adverse reaction reported in 18,440 FDA reports across 9 drugs.
18,440
Total Reports
9
Drugs Involved
Capecitabine
Most Reported Drug
Drugs Associated with PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
Drugs where "PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME" was reported as an adverse event.
| # | Drug | Reports | % of Total |
|---|---|---|---|
| 1 | Capecitabine | 6,616 | |
| 2 | Cabozantinib | 3,079 | |
| 3 | Sorafenib | 2,167 | |
| 4 | Sunitinib Malate | 1,454 | |
| 5 | Regorafenib | 1,432 | |
| 6 | Oxaliplatin | 1,379 | |
| 7 | Lenvatinib | 942 | |
| 8 | Lapatinib | 921 | |
| 9 | Axitinib | 450 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused palmar-plantar erythrodysaesthesia syndrome. Always consult your healthcare provider.